LivaNova’s Sentiva VNS therapy is one of its latest neuromodulation products. [Image courtesy of LivaNova]
During its third quarter, the company swung to profitability and upped its earnings outlook for the rest of 2017.
Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].
Was going to read this article but refuse to go through multiple clicks to see a list. Can you just give the list?
There’s a link on the opening slide where you can download a full spreadsheet of 100 companies and their stock performance. Hope that helps.